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Abstract
Background: Healthcare systems have difficulty incorporating scientific evidence into clinical practice, especially
when science suggests that existing clinical practices are of low-value (e.g. ineffective or harmful to patients). While
a number of lists outlining low-value practices in acute care medicine currently exist, less is known about how best
to initiate and sustain the removal of low-value clinical practices (i.e. de-adoption). This study will develop a
comprehensive list of barriers and facilitators to the de-adoption of low-value clinical practices in acute care
facilities to inform the development of a framework to guide the de-adoption process.
Methods: The proposed project is a multi-stage mixed methods study to develop a framework to guide the
de-adoption of low-value clinical practices in acute care medicine that will be tested in a representative
sample of acute care settings in Alberta, Canada. Specifically, we will: 1) conduct a systematic review of the
de-adoption literature to identify published barriers and facilitators to the de-adoption of low-value clinical
practices in acute care medicine and any associated interventions proposed (Phase one); 2) conduct focus
groups with acute care stakeholders to identify important themes not published in the literature and obtain a
comprehensive appreciation of stakeholder perspectives (Phase two); 3) extend the generalizability of focus
group findings by conducting individual stakeholder surveys with a representative sample of acute care
providers throughout the province to determine which barriers and facilitators identified in Phases one and
two are most relevant in their clinical setting (Phase three). Identified barriers and facilitators will be
catalogued and integrated with targeted interventions in a framework to guide the process of de-adoption in
each of four targeted areas of acute care medicine (Emergency Medicine, Cardiovascular Health and Stroke,
Surgery and Critical Care Medicine). Analyses will be descriptive using a combination of qualitative and
quantitative analyses.
Discussion: There is a growing body of literature suggesting that the de-adoption of ineffective or harmful practices
from patient care is integral to the delivery of high quality care and healthcare sustainability. The framework developed
in this study will map barriers and facilitators to de-adoption to the most appropriate interventions, allowing
stakeholders to effectively initiate, execute and sustain this process in an evidence-based manner.
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Background
The challenge of implementing best evidence into
clinical practice is a significant problem in modern
healthcare [1] that can result in inappropriate, inef-
fective, inefficient and unsafe care. This is particularly
problematic in acute care facilities, where large num-
bers of expensive therapies, technologies and treat-
ments are used daily in an effort to save lives [2, 3].
There is a growing body of literature [4] which sug-
gests that the removal (i.e. de-adoption) of ineffective
and potentially harmful (i.e. low-value) clinical prac-
tices is integral to the delivery of high quality care
and the sustainability of our healthcare system [5–8].
This is highlighted by the growing number of initiati-
ves—such as the Choosing Wisely Campaign®—de-
signed to reduce the use of low-value practices.
Previous studies have produced a conceptual model
for de-adoption, [4] and list of candidate practices to
be de-adopted [9]. However, few studies have exam-
ined how to successfully de-adopt an intervention
that is already integrated into clinical practice [4].
Thus, while there is an urgent need to de-adopt prac-
tices that are of low-value, the process of de-adoption
remains poorly understood.
The challenge of translating research into clinical practice
Translating research evidence into clinical practice is
important, especially for patients admitted to acute
care facilities where expensive and rapidly evolving
technologies are used to save lives and reduce suffer-
ing. Yet the lag between the development of scientific
evidence through randomized controlled trials and the
implementation of that evidence into routine clinical
practice remains significant (~17 years) [10]. The In-
stitute of Medicine has identified six contributing fac-
tors: 1) limited knowledge of how to implement
evidence into practice; 2) inefficient methods of dis-
semination; 3) limited evidence on comparative effect-
iveness to guide investments and use of technologies;
4) absence of national standards of care; 5) research
groups and clinical communities working in isolation;
and 6) inadequate assessment of the impact of cost,
societal values and personal preferences [11, 12]. This
results in three types of knowledge-practice gaps:[11,
13] over use (prescription of an intervention despite
scientific evidence indicating it is ineffective or harm-
ful), under use (little to no prescription of an inter-
vention that science has shown to be effective) and
misuse (prescription of an intervention that scientific
evidence has shown to be effective, but it is pre-
scribed for the wrong patients, under the wrong cir-
cumstances), which have important implications for
patient care and outcomes [14].
The case for a focus on acute care facilities
Hospital-based care is a critical component of healthcare
[15]. Hospitals provide necessary treatment to patients
with life and limb threatening illnesses, and play a vital
role in the prevention of morbidity and mortality [16].
Patients treated in acute care facilities are the sickest in
the healthcare system, with a wide range of complex
medical problems that require urgent treatment (e.g.
casting fractures, complex surgical and medical inter-
ventions, life support technologies in intensive care units
[ICU], etc.). In 2011, acute care facilities across member
countries of the Organization for Economic Co-
Operation and Development (OECD) recorded approxi-
mately 31 emergency department visits per 100 mem-
bers of the population, marking a 5.2% increase in the
total number of visits to emergency departments over
the past decade [17]. At the same time, hospitalisation
rates have increased in about one-third of OECD coun-
tries, with curative or rehabilitative inpatient care ac-
counting for more than a third of health spending in
some countries [18]. Rising utilization, resource con-
straints and resultant capacity strain threaten the current
state of our acute care systems [19]. Moreover, translat-
ing research evidence into best practice is especially
problematic in the care of acutely ill patients where
treatment is time sensitive and multiple expensive tests,
treatments and technologies are concomitantly used in
an attempt to preserve life or limb [20]. Given existing
fiscal climates, aging populations, and the proliferation
of advanced clinical treatments, utilization of services
may exceed the financial and human resource capacities
of our healthcare system [21, 22].
The need to identify and de-adopt low-value clinical
practices
Knowledge translation (KT) is a continuous quality
improvement process largely focused on getting evidence
into practice (i.e. adoption) [23]. However, burgeoning em-
phasis has recently been placed on the advancement of
healthcare agendas that preference the removal (i.e. de-
adoption) of health technologies and clinical practices that
are of low-value (i.e. ineffective or harmful to patients),
given the strong potential to reduce preventable harm,
simplify care, and reallocate resources to effective, high-
value therapies. The push to expand KT activities to
include de-adoption is essential, as challenges abound
when it comes to the removal of established therapies no
longer supported by evidence. For example, a number of
studies published in top clinical journals [24, 25] have dem-
onstrated that fluid resuscitation with albumin has no effect
on meaningful clinical outcomes for the majority of patients,
and is harmful when used in patients with traumatic brain
injury [24]. However, many patients (including some with
traumatic brain injury) continue to be prescribed albumin
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[26]. Given that a growing body of research suggests that
low-value practices are common in medicine, [4] and that
the existence and widespread publication of new, more ro-
bust evidence has repeatedly been shown to fall short of
catalysing important clinical practice change, [27, 28] the
challenge is to find effective ways to initiate, execute and
sustain a process of de-adoption to improve quality and
value in healthcare.
In direct response to this challenge, this study will
catalogue top barriers and facilitators to de-adoption
in the development of an applied framework to guide
the systematic de-adoption of low-value clinical prac-
tices in acute care medicine. Specifically, the existing
evidence base of published barriers and facilitators to
de-adoption will be analyzed to inform stakeholder
focus groups and the development of a survey instru-
ment to determine top barriers and facilitators to de-
adoption in a representative sample front line pro-
viders and decision-makers from 14 acute care facil-
ities across Alberta, Canada. The outcome will be an
applied strategy to facilitate the removal of practices
that are no longer supported by best evidence.
Objectives
Overarching objective
To develop a strategy to guide the de-adoption of
low-value clinical practices within adult acute care
medicine. We intend to accomplish this objective
through:
Specific objectives
1. A systematic review of evidence-based barriers and
facilitators to de-adoption and associated
interventions.
2. An assessment of the top barriers and facilitators to
de-adoption in a single healthcare system.
3. The development of a framework that integrates
barriers and facilitators with specific interventions to
guide the process of de-adoption.
Methods/Design
Study design
We propose to identify and catalogue the top barriers
and facilitators to the de-adoption of low-value clinical
practices in a representative sample of adult acute care
settings in Alberta in an effort to build an evidence-
based applied framework that will guide the process of
de-adoption. This three phase mixed methods study is
the initial step in a program of research that will launch
and sustain a systematic and customizable de-adoption
strategy in adult acute care medicine. The framework
of barriers and facilitators resulting from this project
will ultimately support clinical and health policy
decision-making and improve the quality of care pa-
tients receive. In line with the World Health
Organization (WHO), we define acute care as a clinical
service that responds to immediately life- or limb-
threatening health conditions, encompassing a range of
clinical healthcare functions, including emergency care,
urgent care, short-term stabilization, pre-hospital care,
critical care and trauma care & acute care surgery [16].
Moreover, we divide low-value clinical practices into
two categories: those that are ineffective (i.e. do not
produce any significant or desired effect) and those that
are harmful (i.e. where the risk of harm outweighs any
benefit).
To ensure feasibility of the study we have restricted
our focus to four areas of specialization in acute care
medicine—Emergency, Cardiovascular Health and
Stroke, Surgery and Critical Care. Our sampling
frame will consist of the 14 adult acute care facilities
in Alberta, Canada that have an Emergency Depart-
ment, Operating Room, Cardiovascular Coronary Care
Unit and Intensive Care Unit. These hospitals were
selected because they will provide a population-based
sample representative of the broad spectrum of ter-
tiary, teaching, and community settings in the Alberta
acute care landscape. Moreover, Alberta is an ideal lo-
cation to pilot test this work because the recent over-
haul of health system governance in the province for
quality and safety has led to the establishment of a
province-wide tapestry of integrated Strategic Clinical
Networks (SCNs) [29] whose implementation has cre-
ated a mandate and mechanism to conduct applied
population-based research. The SCNs are provincial
teams of healthcare providers, researchers, govern-
ment representatives and patients and families tasked
with developing a strategy to strengthen clinical en-
gagement and improve the delivery of evidence-
informed care. We intend to use this unique environ-
ment as a ‘living laboratory’ to evaluate published
barriers and facilitators to de-adoption. Furthermore,
while this work will focus on adults, future work
could be extended to pediatrics and neonatology.
Approach
The proposed study aims to develop a framework to
guide de-adoption in acute care settings using a three
phased approach: 1) we will build on our team’s previ-
ously completed scoping review [4] to conduct a
systematic review of the barriers and facilitators to de-
adoption (Phase one); 2) we will conduct focus groups
with acute care stakeholders to identify important bar-
riers and facilitators not published in the literature and
obtain a comprehensive appreciation of stakeholder
perspectives; (Phase two); 3) we will extend the
generalizability of focus group findings by conducting
Parsons Leigh et al. BMC Health Services Research  (2017) 17:54 Page 3 of 9
individual stakeholder surveys with a representative sam-
ple of acute care providers throughout the province to
allow us to better understand barriers and facilitators to
de-adoption (Phase three). Analyses will be descriptive
using a combination of qualitative and quantitative ana-
lyses (Fig. 1).
Systematic review (Phase one)
Objective
To conduct a systematic review of published barriers and
facilitators to the de-adoption of low-value clinical prac-
tices in adult acute care medicine and associated interven-
tions listed as effective. This protocol was developed
according to the Preferred Reporting Items in Systematic
Reviews and Meta-analyses (PRISMA) statement, [30] has
been registered in PROSPERO International Prospective
Register of Systematic Reviews (CRD42016050234)
(Additional file 1). We define barriers and facilitators as
factors that impede or promote use of best evidence in
clinical practice. We define de-adoption as the discontinu-
ation of a clinical practice after it has been previously
adopted.4 A comparison group is not required as we will
be looking for studies that describe barriers and facilita-
tors including observational studies. However, if evalu-
ation studies are identified, details on the comparison
group will be assessed including patients and care setting.
Search strategy
The search strategy was designed using our existing
published scoping review of de-adoption, [30] updating
the systematic search and restricting our focus to cita-
tions describing barriers and facilitators. To update this
review we will search the following electronic databases
from March 5, 2014 to Fall 2016: PubMed, Medline,
EMBASE, CINAHL and the Cochrane Library. A search
of the ‘grey’ literature will also be conducted using the
CADTH tool for searching grey literature. Bibliographies
of retrieved articles will be searched for additional rele-
vant articles. Additional information will be requested
from study authors if necessary.
The search terms are specific to articles reporting de-
adoption, including text words that include combina-
tions and synonyms of de-adoption and healthcare tech-
nologies. Appropriate wildcards will be used to account
for plurals and variations in spelling. Appendix outlines
the proposed MEDLINE search strategy.
Eligibility criteria
We will include English language citations that refer to
barriers or facilitators to the de-adoption of any clinical
practice in adult patients (age ≥ 18 years) with medical,
surgical, or psychiatric illnesses in any healthcare setting.
All original and non-original quantitative and qualitative
research citations will be eligible.
Outcomes
The exact list of outcomes is unknown; however, it is
likely to include: barriers, facilitators and interventions
designed to target barriers or complement facilitators.
We define barriers and facilitators as factors that influ-
ence the discontinuation of a clinical practice after it has
been previously adopted
Citation selection
Prior to the screening of titles and abstracts, the citation
screening form will be calibrated through pilot testing.
Two investigators will independently review a random
sample of 50 citations from the literature search, and the
inclusion/exclusion criteria will be serially revised until
citation selection is reliable (k > = 0.8). The same two
investigators will then independently review citations
through a two-step process. First, the titles and abstracts
of all citations will be screened against inclusion criteria.
Second, the full text of any citation categorized as
include or unclear by either investigator will be reviewed
to determine whether it meets eligibility criteria.
Study sites for data collection
• Foothills Medical Centre, Calgary, Alberta
• Peter Lougheed Centre, Calgary, Alberta
• Rockyview General Hospital, Calgary, Alberta
• South Health Campus, Calgary, Alberta
• Red Deer Regional Hospital, Red Deer, Alberta
• Grey Nuns Community Hospital, Edmonton, Alberta
• Misericordia Community Hospital, Edmonton, Alberta
• Royal Alexandra Hospital, Edmonton, Alberta
• University of Alberta Hospital, Edmonton, Alberta
• Sturgeon Community Hospital, St. Albert, Alberta
• Northern Lights Regional Health Centre, Fort McMurray, Alberta
• Queen Elizabeth II Hospital, Grand Prairie, Alberta
• Chinook Regional Hospital, Lethbridge, Alberta
• Medicine Hat Regional Hospital, Medicine Hat, Alberta
Fig. 1 Methodological schema
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Eligibility disagreements will be resolved between the
reviewers by consensus, and a third reviewer will be
consulted if necessary. Citations returned by the search
will be imported into EndNote X7 (Thomas Reuters,
Philadelphia, PA, USA).
Data extraction
Two reviewers (JPL, DN) will independently extract data
from all included citations using a pre-designed elec-
tronic form that will be pilot tested using a random sam-
ple of 10 citations. Once data are consistently abstracted
(κ ≥0.8), [4] reviewers will proceed with full data extrac-
tion. We will document the type of citation (e.g. original
research), country, study design, study participants (e.g.
disease and/or syndrome under investigation), focus of
citation (e.g. identify low-value practices) recruitment
and sampling and reference standard. For each barrier
and facilitator we will document the name (e.g. lack of
knowledge), type of practice (e.g. therapeutic vs. diag-
nostic, drug vs. non-drug), setting (specialty of unit),
documented clinical application, the primary outcome (e.g.
mortality, length of stay, days free of a particular organ
failure), proposed interventions and the magnitude of the
intervention’s effect (actual effect measure related to the
primary outcome), and subsequent conclusions drawn by
the authors. Any eligibility disagreements encountered
during data extraction will be resolved by consensus, or
arbitration by a third reviewer. Agreement between
reviewers will be quantified using the κ statistic [4].
Quality assessment
For original research studies, the same two reviewers
will independently assess the quality of their method-
ology assessed using the framework of Caldwell et al.,
[31] for evaluating both quantitative and qualitative
study designs.
Analysis
We will present a narrative synthesis of the results. Quan-
titative and qualitative analyses will be performed. Agree-
ment on data abstraction and article classification will be
assessed with Cohen κ reliability coefficients [32]. Quanti-
tative analysis will include summaries of the articles using
counts, proportions, mean (standard deviation), or median
(inter-quartile range, IQR) where appropriate. Qualitative
analysis will include development of a comprehensive list
of barriers and facilitators and proposed interventions
identified in the literature and categorized and quantified
using simple numerical counts. Translation of key con-
cepts from all studies will be performed to identify novel
concepts not explored by individual studies and their
overlap, synthesized and refined to identify core themes.
Statistical analyses
All statistical analyses will be performed using Stata SE
13.1 (Stata Corp. LP, College Station, TX, USA). Qualita-
tive analyses will be performed using NVivo-10 (QSR
International Pty Ltd, Burlington, MA, USA).
Outcome
A comprehensive summary of the de-adoption evidence
base, including the identification of published barriers,
facilitators and associated interventions.
Stakeholder focus groups (Phase two)
Objective
To describe perceptions pertaining to de-adoption
among adult acute care stakeholders, including front-
line providers (inclusive), managers and decision makers
responsible for patient care, and patients and family
members in an effort to identify important contextual
factors and themes not published in the literature.
Patients and family members have been added to this
phase of the work because we are particularly interested
in their perceptions of low value care, the role they feel
they can play in de-adopting low value care practices (if
any), and their perceptions of risks and benefits related
to de-adoption.
Design
Focus groups will be conducted with key stakeholders
(e.g. front-line providers (inclusive), managers and deci-
sion makers responsible for patient care and patient and
family members) in four Strategic Clinical Networks
(Emergency, Cardiovascular Health and Stroke, Surgery
and Critical Care) to elicit their perspectives of barriers
and facilitators to de-adoption from the four areas of
acute care medicine we are targeting. The focus group
methodology was selected for this phase of work because
it is an effective technique for exploring impressions and
experiences and the contextual factors that influence
those perspectives [33]. Focus groups use interaction to
build upon individual comments while encouraging the
expression of unique thoughts, creating a synergy of
ideas not available in one-on-one interviews [33].
Setting
We will conduct 3 focus groups (divided by providers,
decision makers, and patients/family members) with
adult acute care stakeholders in each of the four
Strategic Clinical Networks (n = 12). Each network will
nominate participants. Barriers, facilitators and associ-
ated interventions identified in Phase one will broadly be
used to inform focus group guides. Moreover, an
example for de-adoption of two practices—one related
to harm and one related to no benefit—will be included
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to help frame discussion. This is important because the
barriers and facilitators may be different between low-
value and harmful practices. Customized practice exam-
ples will be chosen in each area of acute care medicine.
Sampling & recruitment
Focus groups rely on purposive samples, chosen in ac-
cordance with the project’s goals [34]. We anticipate that
participants may have different experiences relative to the
following categories: a) geographic location (urban vs. re-
gional); b) type of institution (teaching vs. non-teaching);
and c) area of specialization (Emergency Medicine vs. Car-
diovascular Health and Stroke vs. Surgery vs. Critical
Care); d) stakeholder group (provider vs. decision maker
vs. patient and family member). If variability related to
resources, processes of care and institutional policies con-
tribute to different impressions of de-adoption; these cat-
egories have a high likelihood of bringing them to light.
Because different backgrounds are expected to correspond
to different perspectives on de-adoption, we propose con-
ducting specialty-specific focus groups. This should
ensure that we capture a diversity of views, while main-
taining the richness of perspective related to each area of
specialization. We will not, however, separate focus groups
by type of institution or geographic location, as we antici-
pate that any comparisons that might flow from these
within-specialty differences will help to generate a richer
more in-depth discussion. Thus, a total of 12 focus groups
involving 96–120 participants (8–10/group) are planned.
Participants will be engaged according to standard princi-
ples of qualitative research [35]. A convenience sample of
consecutive consenting acute care stakeholders, including
patient and family members, front-line providers and
managers and decision makers responsible for patient care
from each of the four areas of specialization will be
recruited.
Stakeholders will be eligible if they are currently affili-
ated with an acute care setting (or in the case of patients
and family members, have had previous experiences in
acute care) and if their spoken language is English. Writ-
ten informed consent will be obtained prior to com-
mencement of the focus group. Focus groups will be
moderated by a researcher trained in qualitative
methods (JPL), and a semi-structured focus group guide
designed to elicit participants’ perceptions of barriers
and facilitators to de-adoption in the acute care setting
they are most affiliated with will be followed. Each focus
group will include an overview to introduce the purpose
and agenda, an icebreaker exercise to familiarize the par-
ticipants with each other, a series of questions which
proceed from general to specific, and a summary to
highlight and verify key points [33]. Domains of inquiry
will be identified from the systematic review and discus-
sion among the investigators. The focus group guide will
be pilot-tested on a small group of specialty-specific
stakeholders to refine the wording and flow of questions.
Because we will use an iterative approach to data
analysis, questions will likely be added or subtracted as
the study progresses.
Analysis
Focus groups will be audio taped, transcribed verbatim,
de-identified, imported into NVivo-10 for data manage-
ment and independently coded by two investigators with
qualitative research experience, drawing on qualitative
content analysis to identify themes and sub-themes. All
focus group participants will be provided with a copy of
the study report to review and comment on as a form of
member-checking. There are no sample size consider-
ations per se for the qualitative component of the
proposed study. We will develop graphical summaries of
the data to identify when asymptotes in data collection
have been reached and no new themes (i.e. barriers and
facilitators) are identified, indicating that the boundaries
of the phenomenon have been tapped.
Outcome
A description of stakeholder perceptions of de-adoption
and the identification of important themes not published
in the literature.
Stakeholder surveys (Phase three)
Objective
To determine which of the barriers and facilitators iden-
tified through the systematic review and focus groups
are most relevant to frontline providers working in adult
acute care settings.
Design
Individual stakeholder surveys will be conducted with a
representative sample of front line providers (e.g. nurses
(bedside, clinician and practitioner), physicians (attend-
ing and resident), pharmacists), and those in leadership
positions (e.g., medical director, unit manager) across 14
adult acute care facilities in Alberta. Survey items will be
generated from the barriers and facilitators identified in
the systematic review and focus groups, extending the
generalizability of those findings. Using a 7-point Likert
scale, survey respondents will be asked to rate barriers
and facilitators according to their importance as oppor-
tunities for improving the de-adoption of low-value clin-
ical practices (ineffective, harmful) within their specific
settings (Emergency Department, Operating Room, Car-
diovascular Coronary Care Unit and Intensive Care
Unit) and suggest additional ideas using open response
questions. Using a similar scale, providers will also be
asked to rate proposed interventions according to their
perceived level of effectiveness to initiate and sustain
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practice change within their specific clinical setting. All
respondents will be asked to identify the top 5 barriers
and facilitators that are most important in their clinical
setting for the de-adoption of ineffective practices, the
top 5 for harmful practices, and the top 5 interventions.
We will request identifiable data in the survey (age, gen-
der, number of years working in acute care, primary
specialization, role in organization, type of institution
currently working in) to determine whether and how
perceptions differ by practice setting, hospital type (ter-
tiary vs. community vs. regional) and provider character-
istics (e.g. MDs vs. RNs vs. R.PH).
Sampling & recruitment
A stratified random sample (using the characteristics
outlined below) of frontline providers across the provin-
cial acute care spectrum (n = 2,285 providers sampled)
will be targeted using a clear and easy to understand
electronic survey (SurveyMonkey, Palo Alto, CA, USA).
Our sampling frame will be developed from the frontline
membership lists of the participating units (Emergency,
Cardiovascular Health and Stroke, Surgery, Critical
Care) and electronic surveys will be sent to potential re-
spondents via email. Our targets include 400 completed
surveys from each of the four target areas of acute care
medicine (n = 1,600), with relatively equal distribution
across hospital (n = 14), provider and unit characteristics
(~30 surveys per unit from each of the 14 hospitals).
Our goal for survey recruitment is to capture a diverse
representation of frontline providers, including nurses
(bedside, clinician and practitioner), physicians (attend-
ing and resident), pharmacists and those in leadership
positions (unit manager, member of the executive) with
different characteristics (tertiary & community, teaching
& non-teaching, variation in specialization) to generate a
representative list of barriers and facilitators to de-
adoption. Three survey reminders (two weeks apart) will
be sent to everyone in the sampling frame.
Analysis
Quantitative analyses will describe barriers (e.g. culture
resistant to change) and facilitators (e.g. local champion)
to de-adoption reported in the individual surveys, result-
ing in a comprehensive list. We will present global data
to describe the importance of each barrier and facilitator
using medians and interquartile range. We will also re-
port the proportion of knowledge users that indicated
specific barriers and facilitators as being among the top
5 most important along with their respective binomial
95% confidence. We will present detailed tabulations of
survey responses by provider (RN, MD, R.PH), hospital
(tertiary vs. community, teaching vs. non-teaching) and
practice setting (e.g. surgery vs. critical care) characteris-
tics. The significance of observed differences in reported
barriers and facilitators will be evaluated using Chi-
square tests and the analysis of variance (ANOVA). It is
anticipated that we will perform quantitative analyses on
approximately 1,600 stakeholder surveys (2, 285 surveys
offered with 70% response rate targeted) that will
provide binomial confidence intervals of ±2.4%.
Outcome
Determination of which facilitators, barriers and inter-
ventions identified in the systematic review and focus
groups are most relevant to frontline providers currently
working in acute care.
Main deliverable
Data from all three phases of work will be synthesized to
inform the development of an applied framework to
guide the process of de-adoption across the spectrum of
acute care medicine. Specifically, barriers and facilitators
to de-adoption identified through this work will be cata-
logued and differentiated by their applicability to prac-
tice setting (Emergency Department, Operating Room,
Cardiovascular Coronary Care Unit and Intensive Care
Unit), hospital characteristics (tertiary vs. community vs.
regional), provider characteristics (MD vs. RN vs.R.PH)
and the reason for de-adoption (lack of efficacy vs. po-
tential to cause harm). We will then integrate findings
with a developed list of targeted interventions (e.g. audit
and feedback) to guide the process of de-adoption in
each of the four areas of specialization (Emergency vs.
Cardiovascular Health and Stroke vs. Surgery vs. Critical
Care). The draft framework will be circulated to focus
group or survey participants who indicate interest, for
feedback and as a form of member-checking. While a
number of lists outlining low-value practices in acute
care medicine currently exist, [36, 37] this applied
framework will map barriers and facilitators to de-
adoption, allowing stakeholders to effectively utilize




Low-value clinical practices that are ineffective or poten-
tially harmful to patients are common in healthcare, in
part because implementing scientific evidence into clin-
ical practice is often a difficult and complex process [4].
This study is essential because it will determine barriers
and facilitators to the de-adoption of low-value clinical
practices in acute care medicine, and provide hospitals
with an applied framework to guide the de-adoption
process. Ensuring that patients receive the right care, at
the right time is the ultimate goal of this study. This is
especially important for the population of patients who
enter into the acute care system requiring urgent life-or-
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limb saving treatment in a time sensitive manner. This
project will help to build a foundation for the creation of
effective strategies to improve the use of best-evidence
by facilitating the removal of practices that are no longer
supported by best evidence. This study is directly aligned
with important system and healthcare needs to increase
quality of care and value for money by facilitating the re-
moval of unnecessary, ineffective and potentially harmful
treatments and technologies in acute care medicine.
Next steps
This study has the potential to improve the care that
acutely ill patients receive during their hospital stay by
identifying and cataloguing top barriers and facilitators to
the de-adoption of low-value and harmful clinical practices
to create an applied framework to guide the de-adoption
process in acute care medicine. This is a first step towards
improving patient care. We intend to test and implement
our de-adoption strategy through a series of future pro-
jects: (1) evaluate the framework by pilot testing one KT
intervention to de-adopt a single harmful or ineffective
clinical practice that is relevant to each of the four areas of
acute care included in this study (e.g. reducing the use of
albumin for fluid resuscitation); (2) compare the impact of
our de-adoption strategy for practices that are low-value
vs. those that are harmful to patients; (3) Examine the rela-
tionship between de-adoption and long-term clinical and
economic outcomes in a prospective cohort study.
Appendix
Medline search (October 25, 2016)
1. ((abandon* or contradict* or refute* or refuting or
reassess* or re-assess* or obsole* or revers* or de-
list* or de-list* or disinvest* or dis-invest* or discon-
tinu* or dis-continu* or decommission* or de-
commission* or deadopt* or de-adopt* or de-
implement* or deimplement* or “health care’ with-
draw*” or (no adj benefit*)) adj5 (healthcare or
technolog* or device* or intervention* or health
practi?e* or medical or medical practi?e* or proce-
dur* or drug or drugs or biotechnology*)).tw.
2. limit 1 to English language
3. limit 2 to animals
4. limit 2 to (animals and humans)
5. 3 not 4
6. 2 not 5
7. limit 6 to (“all infant (birth to 23 months)” or
“newborn infant (birth to 1 month)” or “infant (1 to
23 months)” or “preschool child (2 to 5 years)” or
“child (6 to 12 years)”)
8. 6 not 7
9. Limit 8 to yr= “2014-Current”
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